Last updated on July 2019

A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis

Brief description of study

This study is a prospective, multicenter, open-label, single-arm effectiveness and safety study in participants with progressive multiple sclerosis (PMS).

Clinical Study Identifier: NCT03523858

Find a site near you

Start Over

MS Center of California

Newport Beach, CA United States
  Connect »

The Elliot Lewis Center

Wellesley, MA United States
  Connect »

Neurology Clinic PC

Cordova, TN United States
  Connect »

Neurology Center of San Antonio

San Antonio, TX United States
  Connect »

Recherche Sepmus, Inc.

Greenfield Park, QC Canada
  Connect »


Ciudad Guatemala, Guatemala
  Connect »

Catharina ziekenhuis

Eindhoven, Netherlands
  Connect »


Rotterdam, Netherlands
  Connect »

Zuyderland Medisch Centrum

Sittard-Geleen, Netherlands
  Connect »

University of Pennsylvania

Philadelphia, PA United States
  Connect »

SC3 Research Group, Inc

Pasadena, CA United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.